Table 1.
All Reference Methods |
||||
---|---|---|---|---|
POS | NEG | TOTAL | ||
ID NOW | POS | 282 | 138 | 420 |
NEG | 119 | 2781 | 2900 | |
TOTAL | 401 | 2919 | 3320 | |
Xpert Xpress RT-PCR |
||||
POS | NEG | TOTAL | ||
ID NOW | POS | 56 | 23 | 79 |
NEG | 41 | 700 | 741 | |
TOTAL | 97 | 723 | 820 | |
Panther (Fusion) RT-PCR |
||||
POS | NEG | TOTAL | ||
ID NOW | POS | 75 | 56 | 131 |
NEG | 36 | 879 | 915 | |
TOTAL | 111 | 935 | 1046 | |
Panther TMA |
||||
POS | NEG | TOTAL | ||
ID NOW | POS | 151 | 59 | 210 |
NEG | 42 | 1202 | 1244 | |
TOTAL | 193 | 1261 | 1454 |
POS = positive; NEG = negative; PPA = positive percentage agreement; NPA = negative percent agreement; OPA = overall percent agreement; TMA = Transcription mediated amplification).
(a)PPA: 70.3% (95% CI: 65.6 – 74.8%)
NPA: 95.3% (95% CI: 94.4 – 96.0%)
OPA: 92.3% (95% CI: 91.3 – 93.2%)
(b) PPA: 57.7% (95% CI: 47.3 – 67.7%)
NPA: 96.8% (95% CI: 95.3 – 98.0%)
OPA: 92.2% (95% CI: 90.1 – 93.9%)
(c) PPA: 67.6% (95% CI: 58.0 – 76.2%)
NPA: 94.0% (95% CI: 92.3 – 95.4%)
OPA: 91.2% (95% CI: 89.3 – 92.9%)
(d)PPA: 78.2% (95% CI: 71.7 – 83.8%)
NPA: 95.3% (95% CI: 94.0 – 96.4%)
OPA: 93.1% (95% CI: 91.6 – 94.3%)